Competitive displacement of wild-type phospholamban from the Ca2+-free cardiac calcium pump by phospholamban mutants with different binding affinities

Current Therapeutic Research - Clinical and Experimental

Volumn 76, Issue , 2014, Pages 130-137

  Chen, Zhenhui ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Binding affinity; Cardiac Ca2+ ATPase; Cross linking; Enzyme regulation; Equilibrium; Phospholamban

Indexed keywords

CALCIUM ION; PHOSPHOLAMBAN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE 2A; UNCLASSIFIED DRUG; CALCIUM BINDING PROTEIN; PROTEIN BINDING;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CATALYSIS; CHIMERA; CONTROLLED STUDY; CROSS LINKING; GAIN OF FUNCTION MUTATION; GENE CONSTRUCT; GENE EXPRESSION SYSTEM; LOSS OF FUNCTION MUTATION; MICROSOME; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; WILD TYPE; ANIMAL; BINDING COMPETITION; CALCIUM SIGNALING; GENETICS; HUMAN; METABOLISM; MISSENSE MUTATION; SF9 CELL LINE; SPODOPTERA;

ANIMALS; BINDING, COMPETITIVE; CALCIUM SIGNALING; CALCIUM-BINDING PROTEINS; HUMANS; MUTATION, MISSENSE; PROTEIN BINDING; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; SF9 CELLS; SPODOPTERA;

EID: 84907558283     PISSN: 0011393X     EISSN: 18790313     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2014.08.020     Document Type: Article

References (29)

1. Simmerman H.K., Jones L.R. Phospholamban: protein structure, mechanism of action, and role in cardiac function. Physiol Rev 1998, 78:921-947.
2. MacLennan D.H., Kranias E.G. Phospholamban: a crucial regulator of cardiac contractility. Nat Rev Mol Cell Biol 2003, 4:566-577.
3. Kranias E.G., Hajjar R.J. Modulation of cardiac contractility by the phospholamban/SERCA2a regulatome. Circ Res 2012, 110:1646-1660.
4. Frank K., Kranias E.G. Phospholamban and cardiac contractility. Ann Med 2000, 32:572-578.
5. del Monte F., Harding S.E., Dec G.W., Gwathmey J.K., Hajjar R.J. Targeting phospholamban by gene transfer in human heart failure. Circulation 2002, 105:904-907.
6. Cornea R.L., Jones L.R., Autry J.M., Thomas D.D. Mutation and phosphorylation change the oligomeric structure of phospholamban in lipid bilayers. Biochemistry 1997, 36:2960-2967.
7. 2+ pump and phospholamban in Spodoptera frugiperda (Sf21) cells reveals new insights on ATPase regulation. J Biol Chem 1997, 272:15872-15880.
8. Kimura Y., Kurzydlowski K., Tada M., MacLennan D.H. Phospholamban inhibitory function is activated by depolymerization. J Biol Chem 1997, 272:15061-15064.
9. Simmerman H.K., Kobayashi Y.M., Autry J.M., Jones L.R. A leucine zipper stabilizes the pentameric membrane domain of phospholamban and forms a coiled-coil pore structure. J Biol Chem 1996, 271:5941-5946.
10. 2+ pump revealed by intermolecular thiol cross-linking. J Biol Chem 2002, 277:28319-28329.
11. 2+ pump revealed with use of heterobifunctional cross-linking agents. J Biol Chem 2003, 278:48348-48356.
12. 2+-ATPase 2a (SERCA2a) protein binding interactions in human cardiac sarcoplasmic reticulum vesicles using chemical cross-linking. J Biol Chem 2012, 287:7582-7593.
13. 2+ pump reveals stoichiometry and dynamic interactions between the two proteins. Biochem J 2011, 439:313-319.
14. Mueller B., Karim C.B., Negrashov I.V., Kutchai H., Thomas D.D. Direct detection of phospholamban and sarcoplasmic reticulum Ca-ATPase interaction in membranes using fluorescence resonance energy transfer. Biochemistry 2004, 43:8754-8765.
15. Chen L.T., Yao Q., Soares T.A., Squier T.C., Bigelow D.J. Phospholamban modulates the functional coupling between nucleotide domains in Ca-ATPase oligomeric complexes in cardiac sarcoplasmic reticulum. Biochemistry 2009, 48:2411-2421.
16. Karim C.B., Zhang Z., Howard E.C., Torgersen K.D., Thomas D.D. Phosphorylation-dependent conformational switch in spin-labeled phospholamban bound to SERCA. J Mol Biol 2006, 358:1032-1040.
17. Bidwell P., Blackwell D.J., Hou Z., Zima A.V., Robia S.L. Phospholamban binds with differential affinity to calcium pump conformers. J Biol Chem 2011, 286:35044-35050.
18. 2+ ATPase. Proc Natl Acad Sci U S A 2003, 100:467-472.
19. 2+ pump of cardiac sarcoplasmic reticulum to probe spatial and functional interactions within the transmembrane domain. J Biol Chem 2006, 281:14163-14172.
20. 2+ for binding to SERCA2a by stabilizing a unique nucleotide-dependent conformational state. J Biol Chem 2010, 285:28540-28552.
21. Akin B.L., Hurley T.D., Chen Z., Jones L.R. The structural basis for phospholamban inhibition of the calcium pump in sarcoplasmic reticulum. J Biol Chem 2013, 288:30181-30191.
22. 2+-ATPase by protein kinase A and by anti-phospholamban monoclonal antibody 2D12. J Biol Chem 2007, 282:20968-20976.
23. 2+ pump of cardiac sarcoplasmic reticulum. J Biol Chem 2005, 280:10530-10539.
24. Lockamy E.L., Cornea R.L., Karim C.B., Thomas D.D. Functional and physical competition between phospholamban and its mutants provides insight into the molecular mechanism of gene therapy for heart failure. Biochem Biophys Res Commun 2011, 408:388-392.
25. Gruber S.J., Haydon S., Thomas D.D. Phospholamban mutants compete with wild type for SERCA binding in living cells. Biochem Biophys Res Commun 2012, 420:236-240.
26. Zhai J., Schmidt A.G., Hoit B.D., Kimura Y., MacLennan D.H., Kranias E.G. Cardiac-specific overexpression of a superinhibitory pentameric phospholamban mutant enhances inhibition of cardiac function in vivo. J Biol Chem 2000, 275:10538-10544.
27. Zvaritch E., Backx P.H., Jirik F., Kimura Y., de Leon S., Schmidt A.G., et al. The transgenic expression of highly inhibitory monomeric forms of phospholamban in mouse heart impairs cardiac contractility. J Biol Chem 2000, 275:14985-14991.
28. Haghighi K., Schmidt A.G., Hoit B.D., Brittsan A.G., Yatani A., Lester J.W., et al. Superinhibition of sarcoplasmic reticulum function by phospholamban induces cardiac contractile failure. J Biol Chem 2001, 276:24145-24152.
29. He H., Meyer M., Martin J.L., McDonough P.M., Ho P., Lou X., et al. Effects of mutant and antisense RNA of phospholamban on SR Ca(2+)-ATPase activity and cardiac myocyte contractility. Circulation 1999, 100:974-980.